Adam S. Mostafa
2019
In 2019, Adam S. Mostafa earned a total compensation of $866.2K as Chief Financial Officer and Treasurer at X4 Pharmaceuticals, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,341 |
|---|---|
| Option Awards | $168,771 |
| Salary | $372,275 |
| Stock Awards | $155,819 |
| Other | $1,025 |
| Total | $866,231 |
Mostafa received $372.3K in salary, accounting for 43% of the total pay in 2019.
Mostafa also received $168.3K in non-equity incentive plan, $168.8K in option awards, $155.8K in stock awards and $1K in other compensation.
Rankings
In 2019, Adam S. Mostafa's compensation ranked 9,900th out of 13,971 executives tracked by ExecPay. In other words, Mostafa earned more than 29.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,900 out of 13,971 | 29th |
Division Manufacturing | 3,999 out of 5,701 | 30th |
Major group Chemicals And Allied Products | 1,520 out of 2,200 | 31st |
Industry group Drugs | 1,300 out of 1,886 | 31st |
Industry Biological Products, Except Diagnostic Substances | 288 out of 389 | 26th |
Source: SEC filing on April 28, 2020.
Mostafa's colleagues
We found three more compensation records of executives who worked with Adam S. Mostafa at X4 Pharmaceuticals in 2019.
News
X4 Pharmaceuticals CEO Paula Ragan's 2022 pay jumps 81% to $3.9M
April 25, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021
X4 Pharmaceuticals CEO Paula Ragan's 2019 pay jumps 171% to $2.5M
April 28, 2020
X4 Pharmaceuticals CEO René BCPS' 2018 pay jumps 188% to $3.4M
May 22, 2019